Zhejiang Jiuzhou Pharmaceutical (SHA:603456) redeemed cash management product worth 160 million yuan, according to a Shanghai bourse filing on Friday.
The product was purchased on Aug. 13, 2025, from Industrial and Commercial Bank of China (SHA:601398, HKG:1398).
The pharmaceutical company's shares dropped 4% at the close.